The FDA said it learned about the death, which occurred in January, from a consumer complaint it received on June 10. The FDA said its investigation is in preliminary stages, and it will provide an update as it learns more.
The FDA didn’t say which Abbott formula the baby had consumed or where the formula was produced.
spokesman said at this time there is no evidence to suggest a causal relationship between Abbott’s formulas and this newly reported case.
The spokesman said Abbott was provided with limited product and clinical information to evaluate the case. The company will investigate further if additional information becomes available, he said.
Also popular on WSJ.com: